In Vivo Expansion of CMV-Specific Anti-HIV CAR T Cells Following CMV Superinfection

被引：0

作者：

Johnson, Nathan Michel ^{[1
]}

Wu, Chengxiang ^{[1
]}

Yu, Shan ^{[1
]}

Li, Hui ^{[2
]}

Sahu, Gautam ^{[3
]}

Marx, Preston ^{[1
]}

von Laer, Dorothee ^{[4
]}

Skowron, Gail ^{[5
]}

Shaw, George ^{[2
]}

Junghans, Richard P. ^{[6
]}

Kaur, Amitinder ^{[1
]}

Braun, Stephen E. ^{[1
]}

机构：

[1] Tulane Natl Primate Res Ctr, Covington, LA USA

[2] Univ Penn, Philadelphia, PA 19104 USA

[3] Roger Williams Med Ctr, Providence, RI USA

[4] Med Univ Innsbruck, Innsbruck, Austria

[5] Boston Univ, Sch Med, Boston, MA 02118 USA

[6] IT Bio, Boston, MA USA

来源：

MOLECULAR THERAPY | 2019年 / 27卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

854

引用

页码：393 / 394

页数：2

共 50 条

[11] CMV-specific T cell therapy
Einsele, Hennann
Kapp, Markus
Grigoleit, Goetz Ulrich
BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (01) : 71 - 75
[12] RAPID GENERATION OF CMV-SPECIFIC CD19 CAR T CELLS: PROTOCOL OPTIMIZATION AND CMV-CD19 CAR T CELL CHARACTERIZATION
Lamb, M.
Thakkar, A.
Lee, D. A.
CYTOTHERAPY, 2023, 25 (06) : S235 - S235
[13] Reprogramming T cells of CMV-negative donors with CMV-specific T cell receptor RNA
Thomas, S.
Klobuch, S.
Besold, K.
Plachter, B.
Heemskerk, M. H. M.
Schaft, N.
Voss, R-H
Theobald, M.
Herr, W.
ONKOLOGIE, 2010, 33 : 98 - 98
[14] Clinical Use of CMV-Specific T Cells Derived from CMV-Naive Donors
Hanley, Patrick
Keller, Michael
Roesch, Lauren
Saunders, Devin
Lang, Haili
Davila, Blachy
Duffner, Ulrich A.
Kukadiya, Divyesh
Hoq, Fahmida
Bollard, Catherine M.
BLOOD, 2017, 130
[15] CMV-Specific TCR-Transgenic T Cells for Immunotherapy
Schub, Andrea
Schuster, Ingrid G.
Hammerschmidt, Wolfgang
Moosmann, Andreas
JOURNAL OF IMMUNOLOGY, 2009, 183 (10): : 6819 - 6830
[16] Development of CMV-specific cytotoxic T cells (CMV-Tc) in pediatric renal transplant recipients with CMV viremia
Pizzo, Helen
Shin, Bongha
Garrison, Jon
Huang, Edmund
Malekzadeh, Mohammad
Jordan, Stanley C.
Puliyanda, Dechu
Toyoda, Mieko
PEDIATRIC TRANSPLANTATION, 2021, 25 (08)
[17] Clinical Use of CMV-Specific T Cells Derived From CMV-Naive Donors
Keller, Michael Daniel
Hanley, Patrick J.
Roesch, Lauren
Lang, Haili
Saunders, Devin
Davila, Blachy
Duffner, Ulrich
Kukadiya, Divyesh
Hoq, Fahmida
Bollard, Catherine M.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S164 - S164
[18] Cytomegalovirus-Specific T Cells Expressing Anti-HIV CAR and CMV Vaccine Boost as Immunotherapy for HIV/AIDS: Pre-Clinical Data
Lim, Laura
Holguin, Leo
Li, Shasha
Li, Shirley
Urak, Ryan
Scott, Tristan
Browning, Diana
Stan, Rodica
Le Verche, Virginia
Morris, Kevin
Cardoso, Angelo A.
Burnett, John
Forman, Stephen J.
Zaia, John
Wang, Xiuli
MOLECULAR THERAPY, 2019, 27 (04) : 175 - 175
[19] Development of CMV-specific T cells for the management of transplantation patients
Xue, S. A.
Ghorashian, S.
Pospori, C.
Ahmadi, M.
Holler, A.
Thomas, S.
Stauss, H. J.
HUMAN GENE THERAPY, 2010, 21 (10) : 1422 - 1423
[20] Adoptive transfer of CMV-specific T cells for persistent CMV infection after haploidentical stem cell transplantation: association between antiviral immunity and the improving of quantity and quality of CMV-specific T cells
Pei, X-Y
Zhao, X-Y
J-Liu
Chang, Y-J
Xu, L-P
Zhang, X-H
Han, W.
Chen, Y-H
Huang, X-J
BONE MARROW TRANSPLANTATION, 2017, 52 : S59 - S60

← 1 2 3 4 5 →